| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000005576 |
| Receipt No. | R000006227 |
| Official scientific title of the study | Zenih TX2; Low Profile TAA Endovascular Graft Clinical Study |
| Date of disclosure of the study information | 2011/05/11 |
| Last modified on | 2018/05/14 (Ver. 11) |
| Basic information | ||||
| Official scientific title of the study | Zenih TX2; Low Profile TAA Endovascular Graft Clinical Study | |||
| Title of the study (Brief title) | Zenih TX2; Low Profile TAA Endovascular Graft Clinical Study | |||
| Region |
|
|||
| Condition | ||||
| Condition | fusiform or saccular aneurysms | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To collect safety and effectiveness date from clinical use of the ZTLP |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Device success, Procedural time, Condit usage during the procedure, Clinical utility measures, Morbidity, including the composite rate of major adverse events, Endleak, change in aneurysm size, migration, device patency, device integrity |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Stent graft custody with catheter | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Descending thoracic fusiform aneurysm with diameter >5.0 cm
2) Descending thoracic fusiform aneurysm with a history of growth >0.5 cm per year 3) Descending thoracic saccular aneurysm >10 mm in depth and >20 mm in diameter |
|||
| Key exclusion criteria | <General Exclusion Criteria>
1) Less than 20 years of age 2) Life expectancy less than 2 years 3) Pregnant or breastfeeding or planning on becoming pregnant within 60 months 4) Unwilling to company with the follow-up schedule 5) Inability or refusal to give informed consent 6) Less than 30 days beyond primary endpoint for other investigative drug or device study *Additionally, there is Medical Exclusion Criteria and Anatomical Exclusion Criteria, too. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Cook Incorporated |
| Organization | Cook Incorporated |
| Division name | Regulatory Affairs |
| Address | 750 Daniels Way, Bloomington, IN 47404 US |
| TEL | +1-800-346-2235 |
| Ted.Heise@cookmedical.com | |
| Public contact | |
| Name of contact person | Yasuhito Shimizu |
| Organization | Cook Japan Incorporated |
| Division name | Clinical Affairs |
| Address | Nakano Central Park East, Nakano 4-10-1, Nakano, Tokyo, Japan |
| TEL | 03-6853-9450 |
| Homepage URL | |
| cookjapan-com@umin.net | |
| Sponsor | |
| Institute | Cook Japan Incorporated |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Cook Incorporated |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京慈恵会医科大学附属病院(東京都)、森之宮病院(大阪府)、慶應義塾大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006227 |